Nothing Special   »   [go: up one dir, main page]

MA44131A - Dérivés de 1-(3-tert-butyl-2h-pyrazol-5-yl or 5-tert-butyl-isoxaol-3-yl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro-naphthalenyl) urée et leur utlisation en tant qu'inhibiteurs de p38 mapk - Google Patents

Dérivés de 1-(3-tert-butyl-2h-pyrazol-5-yl or 5-tert-butyl-isoxaol-3-yl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro-naphthalenyl) urée et leur utlisation en tant qu'inhibiteurs de p38 mapk

Info

Publication number
MA44131A
MA44131A MA044131A MA44131A MA44131A MA 44131 A MA44131 A MA 44131A MA 044131 A MA044131 A MA 044131A MA 44131 A MA44131 A MA 44131A MA 44131 A MA44131 A MA 44131A
Authority
MA
Morocco
Prior art keywords
tert
butyl
isoxaol
naphthalenyl
triazolo
Prior art date
Application number
MA044131A
Other languages
English (en)
Inventor
Elisabetta Armani
Carmelida Capaldi
Christopher Hurley
Andrew Stephen Robert Jennings
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of MA44131A publication Critical patent/MA44131A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA044131A 2015-12-23 2016-12-20 Dérivés de 1-(3-tert-butyl-2h-pyrazol-5-yl or 5-tert-butyl-isoxaol-3-yl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro-naphthalenyl) urée et leur utlisation en tant qu'inhibiteurs de p38 mapk MA44131A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15202350 2015-12-23

Publications (1)

Publication Number Publication Date
MA44131A true MA44131A (fr) 2021-05-26

Family

ID=55024005

Family Applications (1)

Application Number Title Priority Date Filing Date
MA044131A MA44131A (fr) 2015-12-23 2016-12-20 Dérivés de 1-(3-tert-butyl-2h-pyrazol-5-yl or 5-tert-butyl-isoxaol-3-yl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro-naphthalenyl) urée et leur utlisation en tant qu'inhibiteurs de p38 mapk

Country Status (5)

Country Link
US (1) US9758521B2 (fr)
EP (1) EP3394060A1 (fr)
AR (1) AR107164A1 (fr)
MA (1) MA44131A (fr)
WO (1) WO2017108738A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10364245B2 (en) * 2017-06-07 2019-07-30 Chiesi Farmaceutici S.P.A. Kinase inhibitors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
US6034057A (en) 1995-07-06 2000-03-07 Zeneca Limited Peptide inhibitors of fibronectine
US6248713B1 (en) 1995-07-11 2001-06-19 Biogen, Inc. Cell adhesion inhibitors
YU25500A (sh) 1999-05-11 2003-08-29 Pfizer Products Inc. Postupak za sintezu analoga nukleozida
GB0028383D0 (en) 2000-11-21 2001-01-03 Novartis Ag Organic compounds
EP1241176A1 (fr) 2001-03-16 2002-09-18 Pfizer Products Inc. Dérivés de purine pour le traitement de l'ischémie
DE60214428T2 (de) 2001-12-20 2007-09-20 Bayer Healthcare Ag 1, 4-dihydro-1, 4-diphenylpyridin-derivate
SE0302487D0 (sv) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
GB0502258D0 (en) 2005-02-03 2005-03-09 Argenta Discovery Ltd Compounds and their use
WO2008043019A1 (fr) 2006-10-04 2008-04-10 Pharmacopeia, Inc Dérivés de 2-(benzimidazolyl) purine substitués en position 8 pour immunosuppression
CN105968110B (zh) * 2011-12-09 2018-04-27 奇斯药制品公司 激酶抑制剂
BR112015029504A2 (pt) * 2013-06-06 2017-07-25 Chiesi Farm Spa inibidores quinase
KR20160015221A (ko) 2013-06-06 2016-02-12 키에시 파르마슈티시 엣스. 피. 에이. 키나아제 억제제

Also Published As

Publication number Publication date
US9758521B2 (en) 2017-09-12
EP3394060A1 (fr) 2018-10-31
WO2017108738A1 (fr) 2017-06-29
US20170183344A1 (en) 2017-06-29
AR107164A1 (es) 2018-03-28

Similar Documents

Publication Publication Date Title
EP3672973A4 (fr) Composés hétérocycliques utilisés en tant qu'inhibiteurs de kinase, compositions comprenant le composé hétérocyclique, et leurs procédés d'utilisation
CY1121831T1 (el) Παραγωγα θειενο [2,3-c] πυρρολ-4-ονης ως αναστολεις της erk
ZA202006944B (en) 2-amino-pyridine or 2-amino-pyrimidine derivatives as cyclin dependent kinase inhibitors
SG11202011513RA (en) Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof
CO2017011754A2 (es) Amidas heterocíclicas como inhibidores de quinasa
IL267090A (en) Amine-disubstituted heterocyclic compounds as ehmt2 inhibitors and methods of using them
MA49401A (fr) Inhibiteurs de la kinase alk2 contenant de l'imidazole
CY1124088T1 (el) Παραγωγα 2,4-θειαζολιδινεδιονης στη θεραπεια διαταραχων του κεντρικου νευρικου συστηματος
UA111804C2 (uk) ПОХІДНІ ПІРОЛО[2,3-d]ПІРИМІДИНУ ЯК ІНГІБІТОРИ ЯНУС-ЗАЛЕЖНИХ КІНАЗ (JAK)
MA40774A (fr) Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38
EA201790395A1 (ru) Производные аминотриазина, подходящие для применения в качестве соединений-ингибиторов tank-связывающей киназы
DK3227297T3 (da) 4,6-substitueret-pyrazolo[1,5-a]pyraziner som janus kinase-inhibitorer
MX2016015565A (es) Ciertos inhibidores de la proteina quinasa.
EP3697791A4 (fr) Composés hétérocycliques, compositions comprenant le composé hétérocyclique, et leurs procédés d'utilisation
EA201692474A1 (ru) Производные 1-(циклопент-2-ен-1-ил)-3-(2-гидрокси-3-(арилсульфонил)фенил)мочевины в качестве ингибиторов cxcr2
EP3697419A4 (fr) Composés hétérocycliques à substitution amine utilisés comme inhibiteurs de l'ehmt2 et dérivés de ces derniers
EA201690523A1 (ru) Триазолопиридины, композиции и способы их применения
EP3541806A4 (fr) Composés hétérocycliques à utiliser en tant qu'inhibiteurs de kinases
CY1122423T1 (el) Παραγωγα πυριμιδινης χρησιμα ως εκλεκτικοι αναστολεις jak3 kai/ή jak1
EP3514155A4 (fr) Composé hétérocyclique et agent de lutte contre les arthropodes nuisibles le contenant
EP3483162B8 (fr) Composé hétérocyclique n-alkylsulfonyle fusionné ou leur sels, pesticide contenant ledit composé et procédé d'utilisation dudit pesticide
DK3452465T3 (da) Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme
EA201890847A1 (ru) Композиции и способы ингибирования бета-лактамазы
EA201891430A1 (ru) Твердые формы замещенных 5,6-дигидро-6-фенилбензо[f]изохинолин-2-аминовых соединений
MA44131A (fr) Dérivés de 1-(3-tert-butyl-2h-pyrazol-5-yl or 5-tert-butyl-isoxaol-3-yl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro-naphthalenyl) urée et leur utlisation en tant qu'inhibiteurs de p38 mapk